Amir A. Toor

3.5k total citations
115 papers, 2.5k citations indexed

About

Amir A. Toor is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Amir A. Toor has authored 115 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hematology, 42 papers in Immunology and 33 papers in Oncology. Recurrent topics in Amir A. Toor's work include Hematopoietic Stem Cell Transplantation (39 papers), Immune Cell Function and Interaction (27 papers) and T-cell and B-cell Immunology (21 papers). Amir A. Toor is often cited by papers focused on Hematopoietic Stem Cell Transplantation (39 papers), Immune Cell Function and Interaction (27 papers) and T-cell and B-cell Immunology (21 papers). Amir A. Toor collaborates with scholars based in United States, Saudi Arabia and France. Amir A. Toor's co-authors include Bart Barlogie, Guido Tricot, Ashraf Badros, Maurizio Zangari, Christopher Morris, Raman Desikan, Elias Anaissie, Louis M. Fink, Eric R. Siegel and Masoud H. Manjili and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Amir A. Toor

113 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir A. Toor United States 26 1.3k 902 709 502 265 115 2.5k
Faiz Anwer United States 23 963 0.7× 782 0.9× 1.1k 1.6× 458 0.9× 342 1.3× 328 2.5k
Prasad Mathew United States 28 1.3k 1.0× 587 0.7× 501 0.7× 212 0.4× 328 1.2× 90 3.0k
Peter Mollee Australia 25 841 0.6× 997 1.1× 936 1.3× 300 0.6× 444 1.7× 180 2.5k
H. Jean Khoury United States 30 1.9k 1.5× 538 0.6× 783 1.1× 635 1.3× 620 2.3× 117 3.1k
Inho Kim South Korea 21 877 0.7× 545 0.6× 516 0.7× 199 0.4× 283 1.1× 183 1.7k
Stephen Schey United Kingdom 20 1.1k 0.9× 677 0.8× 894 1.3× 150 0.3× 218 0.8× 71 1.8k
Leona Holmberg United States 24 1.0k 0.8× 654 0.7× 809 1.1× 411 0.8× 361 1.4× 99 2.2k
Sung‐Soo Yoon South Korea 35 1.8k 1.4× 1.6k 1.8× 1.5k 2.1× 630 1.3× 637 2.4× 342 4.2k
Muneer H. Abidi United States 22 1.5k 1.1× 977 1.1× 1.5k 2.1× 208 0.4× 321 1.2× 92 2.7k
Elliott F. Winton United States 23 1.4k 1.1× 841 0.9× 454 0.6× 254 0.5× 1.2k 4.7× 81 2.5k

Countries citing papers authored by Amir A. Toor

Since Specialization
Citations

This map shows the geographic impact of Amir A. Toor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir A. Toor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir A. Toor more than expected).

Fields of papers citing papers by Amir A. Toor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir A. Toor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir A. Toor. The network helps show where Amir A. Toor may publish in the future.

Co-authorship network of co-authors of Amir A. Toor

This figure shows the co-authorship network connecting the top 25 collaborators of Amir A. Toor. A scholar is included among the top collaborators of Amir A. Toor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir A. Toor. Amir A. Toor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahid, Zainab, Aaron Etra, John E. Levine, et al.. (2024). Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee. Transplantation and Cellular Therapy. 30(5). 540.e1–540.e13. 3 indexed citations
2.
Vecchié, Alessandra, Georgia Thomas, Edoardo Bressi, et al.. (2021). Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience. Cardio-Oncology. 7(1). 40–40. 2 indexed citations
3.
Ansari, Amir, et al.. (2021). Transient left ventricular dysfunction following chimeric antigen receptor T‐cell‐mediated encephalopathy: A form of stress cardiomyopathy. SHILAP Revista de lepidopterología. 3(1). 231–234. 2 indexed citations
4.
Ansari, Amir, et al.. (2021). Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia. SHILAP Revista de lepidopterología. 9(10). e04788–e04788. 1 indexed citations
5.
Qayyum, Rehan, et al.. (2020). Increased Inhibitory KIR-Ligand Interactions Confer Relapse Protection Following HLA Matched Unrelated Donor HCT for AML. Blood. 136(Supplement 1). 47–47. 1 indexed citations
6.
Simmons, Gary, Bernard Fisher, Jason Reed, et al.. (2019). Reduced plasma ascorbic acid levels in recipients of myeloablative conditioning and hematopoietic cell transplantation. European Journal Of Haematology. 103(4). 329–334. 9 indexed citations
7.
Saleh, Tareq, Liliya Tyutyunyk‐Massey, Graeme Murray, et al.. (2018). Tumor cell escape from therapy-induced senescence. Biochemical Pharmacology. 162. 202–212. 128 indexed citations
8.
Hall, C. E., Vishal N. Kopardé, Myrna G. Serrano, et al.. (2017). Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity. PLoS ONE. 12(8). e0178763–e0178763. 13 indexed citations
9.
Toor, Amir A., et al.. (2016). On the organization of human T-cell receptor loci: log-periodic distribution of T-cell receptor gene segments. Journal of The Royal Society Interface. 13(114). 20150911–20150911. 4 indexed citations
10.
Sulek, Jay, et al.. (2016). The Expression of Cancer/Testis Antigens in Kidney and Bladder Malignancies. 8(2). 1 indexed citations
11.
Schootman, Mario, Amir A. Toor, Patricia Cavazos‐Rehg, et al.. (2015). The utility of Google Trends data to examine interest in cancer screening. BMJ Open. 5(6). e006678–e006678. 104 indexed citations
12.
Toor, Amir A., Roy Sabo, Catherine Roberts, et al.. (2015). Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes. Biology of Blood and Marrow Transplantation. 21(7). 1237–1245. 14 indexed citations
13.
Kmieciak, Maciej, Roy Sabo, Catherine Roberts, et al.. (2012). Distinct Oligoclonal T Cells Are Associated With Graft Versus Host Disease After Stem-Cell Transplantation. Transplantation. 93(9). 949–957. 17 indexed citations
14.
Toor, Amir A., Kyle K. Payne, Roy Sabo, et al.. (2012). Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen‐specific cellular immunity. British Journal of Haematology. 158(6). 700–711. 34 indexed citations
15.
Toor, Amir A., Roy Sabo, Catherine Roberts, et al.. (2011). Favorable Outcomes in Patients with High Donor-Derived T Cell Count after In Vivo T Cell–Depleted Reduced-Intensity Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(5). 794–804. 9 indexed citations
16.
Hassan, Md. Imtaiyaz, Amir A. Toor, & Faizan Ahmad. (2010). Progastriscin: Structure, Function, and Its Role in Tumor Progression. Journal of Molecular Cell Biology. 2(3). 118–127. 30 indexed citations
17.
Smith, Scott E., Amir A. Toor, Tulio E. Rodriguez, & Patrick J. Stiff. (2006). The administration of polymerized human hemoglobin (pyridoxylated) to a jehovah's witness after submyeloablative stem cell transplantation complicated by delayed graft failure. Comprehensive Therapy. 32(3). 172–175. 8 indexed citations
18.
Toor, Amir A., Jacob Joseph, Maria Thomas, et al.. (2005). Cardiac nonamyloidotic immunoglobulin deposition disease. Modern Pathology. 19(2). 233–237. 27 indexed citations
19.
Tricot, Guido, Raman Desikan, Ashraf Badros, et al.. (2002). Clinical activity of arsenic trioxide for the treatment of multiple myeloma. Leukemia. 16(9). 1835–1837. 120 indexed citations
20.
Zangari, Maurizio, Fariba Saghafifar, E. Anaissie, et al.. (2002). Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications. Blood Coagulation & Fibrinolysis. 13(3). 187–192. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026